SILENCE THERAP. SP.ADR/1 Free Cash Flow Generation Index

Latest as of December 2021: 0.80x

SILENCE THERAP. SP.ADR/1 free cash flow generation index. SILENCE THERAP. SP.ADR/1 (XRP2) has a Free Cash Flow Generation Index of 0.80x as of December 2021. Free cash flow of €7.39 Million represents 1% of operating cash flow (€9.19 Million).

FCF Generation Index

0.80x
Free Cash Flow / Operating CF

Free Cash Flow

€7.39 Million
EUR

Operating Cash Flow

€9.19 Million
EUR

Capital Expenditures

€1.80 Million
EUR

Free Cash Flow Generation Index of SILENCE THERAP. SP.ADR/1 (2021–2021)

Free cash flow generation index of SILENCE THERAP. SP.ADR/1 from 2021 to 2021. Historical FCF Generation Index trend for SILENCE THERAP. SP.ADR/1 across 1 annual periods. See XRP2 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

SILENCE THERAP. SP.ADR/1 Free Cash Flow Generation Index by Year (2021–2021)

SILENCE THERAP. SP.ADR/1 free cash flow generation index by year from 2021 to 2021. Year-by-year Free Cash Flow Generation Index for SILENCE THERAP. SP.ADR/1. For the full cash flow conversion analysis, see SILENCE THERAP. SP.ADR/1 cash conversion from operations.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2021 0.80x €7.39 Million €9.19 Million €1.80 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).